Press Room

 

CAPD Letter to CMS on EGWP Plans and the Safe Harbor Rule

CAPD Statement on Medicare Advantage and Part D Drug Pricing Final Rule (CMS-4180-F)

Debra Barrett, Executive Director of the Coalition for Affordable Prescription Drugs, released the following statement today on the…

CAPD Statement on Legislation Introduced by Senators Cornyn and Blumenthal

Debra Barrett, Executive Director of the Coalition for Affordable Prescription Drugs, released the following statement today on legislation…

CAPD Statement on Senate Judiciary Committee Hearing on IP and Drug Pricing

Debra Barrett, Executive Director of the Coalition for Affordable Prescription Drugs, released the following statement ahead of the…

CAPD Statement on the CBO Score of the HHS Safe Harbor Rule

Debra Barrett, Executive Director of the Coalition for Affordable Prescription Drugs, released the following statement today on the…

CAPD Statement on the Introduction of the “Remedy Act”

Debra Barrett, Executive Director of the Coalition for Affordable Prescription Drugs, released the following statement today on the…

CAPD Statement for the Record: Senate Committee on Finance

The Coalition for Affordable Prescription Drugs (CAPD) appreciates the opportunity to submit the following statement for the record…

CAPD Comments on Proposed Rule to Remove Safe Harbor Protection for Rebates

Re: OIG-0936-P: Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor…